Clinical Trials · NCT05628558

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

Phase
N/A
Recruitment status
Unknown
Sponsor
Groupe Maladies hémorragiques de Bretagne
Enrollment
800
Start date
Jul 2020
Locations
1 site, France
Primary endpoint
Influence of different hot spot variants of the F8 gene responsible for hemophilia on the factor VIII pharmacokinetics after desmopressin infusion
View Desmopressin compound reference